Your browser doesn't support javascript.
loading
A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition.
Schiffmann, L M; Brunold, M; Liwschitz, M; Goede, V; Loges, S; Wroblewski, M; Quaas, A; Alakus, H; Stippel, D; Bruns, C J; Hallek, M; Kashkar, H; Hacker, U T; Coutelle, O.
Afiliación
  • Schiffmann LM; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Centre for Molecular Medicine Cologne (CMMC) and Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, CECAD Research Centre, Joseph-Stelzmann-Street 26, 50931 Cologne, Germany.
  • Brunold M; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Street 62, 50937 Cologne, Germany.
  • Liwschitz M; Center for Integrated Oncology (CIO) Cologne-Bonn, Kerpener Street 62, Cologne 50924, Germany.
  • Goede V; Department of Internal Medicine III, St Vinzenz Hospital, Merheimer Street 221-223, 50733 Cologne, Germany.
  • Loges S; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Evangelisches Krankenhaus Bergisch Gladbach, Ferrenbergstr 24, 51465 Bergisch Gladbach, Germany.
  • Wroblewski M; Department for Geriatric Medicine, St Marien Hospital, Kunibertskloster 11-13, 50668 Cologne, Germany.
  • Quaas A; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Alakus H; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Stippel D; Center for Integrated Oncology (CIO) Cologne-Bonn, Kerpener Street 62, Cologne 50924, Germany.
  • Bruns CJ; Institute for Pathology, University of Cologne, Kerpener Street 62, 50937 Cologne, Germany.
  • Hallek M; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Street 62, 50937 Cologne, Germany.
  • Kashkar H; Center for Integrated Oncology (CIO) Cologne-Bonn, Kerpener Street 62, Cologne 50924, Germany.
  • Hacker UT; Department of General, Visceral and Cancer Surgery, University of Cologne, Kerpener Street 62, 50937 Cologne, Germany.
  • Coutelle O; Center for Integrated Oncology (CIO) Cologne-Bonn, Kerpener Street 62, Cologne 50924, Germany.
Br J Cancer ; 116(5): 600-608, 2017 Feb 28.
Article en En | MEDLINE | ID: mdl-28141797
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Mesilato de Imatinib / Bevacizumab / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Mesilato de Imatinib / Bevacizumab / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Alemania